BioCryst Pharmaceuticals Inc (BCRX)
4.23
-0.15
(-3.42%)
USD |
NASDAQ |
Apr 24, 16:00
4.23
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Price: 4.23 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 4.44 | 4.63 | 4.37 | 4.38 | 3.768M |
Apr 22, 2024 | 4.43 | 4.57 | 4.39 | 4.41 | 2.557M |
Apr 19, 2024 | 4.50 | 4.59 | 4.27 | 4.43 | 4.694M |
Apr 18, 2024 | 4.60 | 4.71 | 4.49 | 4.50 | 2.960M |
Apr 17, 2024 | 4.65 | 4.79 | 4.57 | 4.58 | 4.055M |
Apr 16, 2024 | 4.61 | 4.72 | 4.54 | 4.61 | 1.979M |
Apr 15, 2024 | 4.78 | 4.785 | 4.59 | 4.67 | 2.497M |
Apr 12, 2024 | 5.10 | 5.16 | 4.70 | 4.77 | 4.526M |
Apr 11, 2024 | 4.93 | 5.115 | 4.82 | 5.10 | 3.304M |
Apr 10, 2024 | 4.64 | 4.905 | 4.56 | 4.87 | 2.915M |
Apr 09, 2024 | 4.61 | 4.88 | 4.61 | 4.80 | 1.974M |
Apr 08, 2024 | 4.62 | 4.67 | 4.54 | 4.61 | 1.605M |
Apr 05, 2024 | 4.56 | 4.66 | 4.45 | 4.60 | 1.785M |
Apr 04, 2024 | 4.76 | 4.84 | 4.58 | 4.60 | 2.737M |
Apr 03, 2024 | 4.71 | 4.769 | 4.595 | 4.73 | 3.059M |
Apr 02, 2024 | 4.95 | 5.01 | 4.68 | 4.69 | 4.211M |
Apr 01, 2024 | 5.04 | 5.09 | 4.905 | 5.05 | 4.875M |
Mar 28, 2024 | 5.20 | 5.34 | 5.06 | 5.08 | 3.491M |
Mar 27, 2024 | 5.04 | 5.208 | 4.97 | 5.15 | 2.990M |
Mar 26, 2024 | 5.01 | 5.15 | 4.99 | 5.01 | 3.160M |
Mar 25, 2024 | 5.00 | 5.08 | 4.84 | 4.91 | 2.828M |
Mar 22, 2024 | 5.51 | 5.51 | 5.01 | 5.01 | 3.296M |
Mar 21, 2024 | 5.50 | 5.865 | 5.45 | 5.49 | 2.726M |
Mar 20, 2024 | 5.31 | 5.49 | 5.17 | 5.47 | 3.181M |
Mar 19, 2024 | 5.06 | 5.425 | 5.04 | 5.36 | 3.119M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.585
Minimum
Nov 14 2019
19.76
Maximum
Feb 16 2022
8.376
Average
7.61
Median
May 13 2019
Price Benchmarks
AIM ImmunoTech Inc | 0.428 |
Perspective Therapeutics Inc | 1.655 |
Protalix BioTherapeutics Inc | 1.215 |
Electromed Inc | 16.26 |
Armata Pharmaceuticals Inc | 2.51 |
Price Related Metrics
PS Ratio | 2.453 |
Earnings Yield | -27.90% |
Market Cap | 872.01M |